Litcius/Paper detail

Detection of NTRK fusions in glioblastoma: fluorescent in situ hybridisation is more useful than pan-TRK immunohistochemistry as a screening tool prior to RNA sequencing

Amélie Bourhis, Charline Caumont, Isabelle Quintin‐Roué, Elsa Magro, Gurvan Dissaux, Annabelle Remoué, P. Noach, Nathalie Douet‐Guilbert, Romuald Seizeur, Alexandra Tyulyandina, Ulrike Schick, Jean‐Philippe Merlio, Pascale Marcorelles, David Cappellen, Arnaud Uguen

2021Pathology15 citationsDOIOpen Access PDF

Topics & Concepts

Trk receptorImmunohistochemistryBiologyFluorescence in situ hybridizationImmunostainingFish <Actinopterygii>Cancer researchPathologyInternal medicineMedicineReceptorGeneNeurotrophinGeneticsChromosomeFisheryGlioma Diagnosis and TreatmentRNA Research and SplicingChromatin Remodeling and Cancer
Detection of NTRK fusions in glioblastoma: fluorescent in situ hybridisation is more useful than pan-TRK immunohistochemistry as a screening tool prior to RNA sequencing | Litcius